Education
About Us
Working with TipRanks
Follow Us
IEV - ETF AI Analysis
Top Page
iShares Europe ETF (IEV)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several key holdings, such as ASML Holding NV and Nestlé SA, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Geographic Diversification
The ETF invests across multiple European countries, reducing reliance on any single economy.
Healthy Sector Balance
The fund is diversified across sectors like financials, industrials, and healthcare, which helps mitigate risks from sector-specific downturns.
Negative Factors
Underperforming Holdings
Some top positions, like SAP SE and LVMH, have lagged in performance, potentially dragging on overall returns.
Moderate Expense Ratio
The ETF's expense ratio is higher than some low-cost alternatives, which could reduce net returns over time.
Limited U.S. Exposure
With only 4% exposure to U.S. companies, the fund may miss out on growth opportunities in the world's largest economy.
IEV Historical Chart
AUM1.62B
RegionEurope
Expense Ratio0.60%
Beta0.66
IssueriShares
Inception DateJul 25, 2000
Dividend Yield2.19%
Asset ClassEquity
Index TrackedS&P Europe 350
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume119,277
30 Day Avg. Volume312,715
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
75.72Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering357
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IEV Summary
The iShares Europe ETF (IEV) is an investment fund that tracks the S&P Europe 350 Index, which includes 350 of the largest companies across 16 developed European countries. It focuses on well-established, large-cap companies in various industries, such as healthcare, financials, and technology. Some of its top holdings include Nestlé and AstraZeneca, making it a great option for investors looking to diversify their portfolio with exposure to leading European businesses. This ETF offers a chance to benefit from the growth and stability of Europe’s major economies. However, new investors should be aware that its performance can be affected by economic or political changes in Europe.
How much will it cost me?The iShares Europe ETF (IEV) has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is slightly higher than average for ETFs because it tracks a broad index of European large-cap stocks, which requires more management compared to passively managed U.S. index funds.
What would affect this ETF?The iShares Europe ETF (IEV) could benefit from economic recovery and growth in developed European markets, especially if sectors like financials and industrials, which make up a significant portion of its holdings, perform well. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in Europe could negatively impact its performance, particularly for top holdings in industries like healthcare and technology that are sensitive to such factors.
IEV Top 10 Holdings
The iShares Europe ETF (IEV) leans heavily on European blue-chip names, with a noticeable tilt toward financials and industrials. Healthcare giants like Roche and AstraZeneca are steady performers, providing a healthy dose of stability, while ASML’s mixed momentum in the tech sector adds a touch of volatility. SAP, however, has been lagging, dragging on the fund’s overall performance. Nestlé and Novartis offer steady but unspectacular contributions, reflecting the ETF’s broad-based approach. With its focus on developed Europe, the fund captures a diverse economic landscape but remains concentrated in large-cap stalwarts.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.37% | $54.55M | €361.36B | 38.64% | 76 Outperform | |
| Roche Holding AG | 2.14% | $34.72M | CHF257.44B | 37.41% | 73 Outperform | |
| AstraZeneca | 2.14% | $34.66M | £209.51B | 28.65% | 80 Outperform | |
| HSBC Holdings | 1.99% | $32.24M | HK$1.97T | 46.18% | 80 Outperform | |
| SAP SE | 1.93% | $31.23M | €246.20B | -12.66% | 66 Neutral | |
| Nestlé SA | 1.93% | $31.18M | CHF196.65B | 15.97% | 71 Outperform | |
| Novartis AG | 1.92% | $31.18M | CHF200.64B | 20.35% | 80 Outperform | |
| Shell (UK) | 1.62% | $26.30M | £154.81B | 8.06% | 73 Outperform | |
| Siemens | 1.58% | $25.67M | €181.39B | 21.30% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.44% | $23.25M | €307.60B | -3.60% | 78 Outperform |
IEV Technical Analysis
Positive
―
Price Trends
66.40
Positive
65.27
Positive
62.64
Positive
Market Momentum
0.50
Negative
65.40
Neutral
82.67
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IEV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 66.59, equal to the 50-day MA of 66.40, and equal to the 200-day MA of 62.64, indicating a bullish trend. The MACD of 0.50 indicates Negative momentum. The RSI at 65.40 is Neutral, neither overbought nor oversold. The STOCH value of 82.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IEV.
IEV Peer Comparison
Comparison Results
Performance Comparison
IEV
iShares Europe ETF
68.52
15.60
29.48%
EZU
iShares MSCI Eurozone ETF
―
―
―
BBEU
JPMorgan BetaBuilders Europe ETF
―
―
―
IEUR
iShares Core MSCI Europe ETF
―
―
―
FEZ
SPDR EURO STOXX 50 ETF
―
―
―
HEDJ
WisdomTree Europe Hedged Equity Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents